Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Ann Denise Thor

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Thor, Ann

Item TypeName
Academic Article Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
Academic Article c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.
Academic Article HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer.
Academic Article Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.
Academic Article erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.
Academic Article Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.
Academic Article Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
Academic Article Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Academic Article HER2 and response to paclitaxel in node-positive breast cancer.
Academic Article Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.
Academic Article Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.
Academic Article Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
Academic Article Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin.
Academic Article Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation.
Academic Article Invasive micropapillary carcinoma of the breast: a prognostic study.
Academic Article Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
Academic Article HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.
Academic Article Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer.
Academic Article Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions.
Academic Article Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
Academic Article Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients.
Academic Article Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
Academic Article Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells.
Concept Receptor, ErbB-2
Concept Receptor, ErbB-3
Academic Article Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.
Academic Article Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Academic Article The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells.
Academic Article Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells.
Concept Receptor, ErbB-4

Search Criteria
  • Receptor
  • ErbB
  • 4

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)